Our Team
Matthew Gdovin, Ph.D, Chief Science Officer & Founder
Matthew Gdovin, Ph.D, Chief Science Officer & Founder
Matthew Gdovin, Ph.D, Chief Science Officer & Founder
Dr. Gdovin received his PhD in Physiology from Dartmouth College in Hanover, NH. His 21-year research career at the University of Texas at San Antonio (UTSA) focused on pH regulation where he discovered the ability to disrupt intracellular pH regulation in cancer to cause cancer cell death. He is the inventor of VNB’s technology and a lea
Dr. Gdovin received his PhD in Physiology from Dartmouth College in Hanover, NH. His 21-year research career at the University of Texas at San Antonio (UTSA) focused on pH regulation where he discovered the ability to disrupt intracellular pH regulation in cancer to cause cancer cell death. He is the inventor of VNB’s technology and a leading expert in the field of light-activated intracellular acidosis to cause cancer cell death. Dr. Gdovin oversees all research activities pertaining to Vitanova Biomedical's nanoparticle based cancer therapy.
Tom Roberts, Chairman, Board of Directors
Matthew Gdovin, Ph.D, Chief Science Officer & Founder
Matthew Gdovin, Ph.D, Chief Science Officer & Founder
Tom has 30 years of experience in significant leadership and executive management roles at large corporations, mid-caps and start-up companies in the medical device and biotech sectors including leadership positions at Acelity and Hoffmann-La Roche. He has been responsible for billion-dollar global healthcare brands, and the successful de
Tom has 30 years of experience in significant leadership and executive management roles at large corporations, mid-caps and start-up companies in the medical device and biotech sectors including leadership positions at Acelity and Hoffmann-La Roche. He has been responsible for billion-dollar global healthcare brands, and the successful development and commercialization of numerous healthcare products. Prior to joining Vitanova, he served as President, Chief Executive Officer and Board Director at Invictus Medical, a start-up healthcare technology company. Tom successfully raised approximately $10 million in financing and directed the full development of a novel healthcare technology from concept to FDA clearance and market entry. He received his B.S. in Biology from Denison University, and his M.B.A. from Indiana Wesleyan University.
Greg Espenhover, Chief Financial Officer & Founder
Matthew Gdovin, Ph.D, Chief Science Officer & Founder
Greg Espenhover, Chief Financial Officer & Founder
Greg is an entrepreneur and dedicated CPA with over 30 years’ experience in providing accounting, tax, and business consulting services to a diverse set of businesses. Since 1988, he has been a CPA under the Texas State Board of Accountancy. Greg is also a member of the American Institute of Certified Public Accountants, the Texas Society
Greg is an entrepreneur and dedicated CPA with over 30 years’ experience in providing accounting, tax, and business consulting services to a diverse set of businesses. Since 1988, he has been a CPA under the Texas State Board of Accountancy. Greg is also a member of the American Institute of Certified Public Accountants, the Texas Society of Certified Public Accountants and holds the Certified Information Technology Professional designation issued by the AICPA. In 1999, Greg became a Shareholder and Partner with Davidson Freedle Espenhover & Overby, P.C., providing accounting, auditing, consulting, and tax services to small to medium size private companies.